Sterling Capital Management LLC cut its holdings in Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) by 35.0% in the first quarter, Holdings Channel.com reports. The fund owned 14,464 shares of the company’s stock after selling 7,777 shares during the quarter. Sterling Capital Management LLC’s holdings in Addus HomeCare were worth $1,355,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the business. Royal Bank of Canada lifted its stake in shares of Addus HomeCare by 24.3% in the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after purchasing an additional 1,347 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Addus HomeCare by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after buying an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Addus HomeCare by 6.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after buying an additional 2,952 shares during the last quarter. Jane Street Group LLC increased its position in Addus HomeCare by 387.6% during the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after buying an additional 8,780 shares during the last quarter. Finally, Intech Investment Management LLC raised its holdings in Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock valued at $1,420,000 after buying an additional 4,439 shares in the last quarter. 95.35% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of analysts have weighed in on ADUS shares. Wall Street Zen cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 21st. Citizens Jmp reissued a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Monday, May 18th. Weiss Ratings downgraded Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 22nd. Finally, Barclays reduced their target price on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a report on Friday, May 15th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Addus HomeCare currently has a consensus rating of “Moderate Buy” and an average price target of $131.00.
Addus HomeCare Stock Performance
NASDAQ:ADUS opened at $98.05 on Tuesday. The firm has a market capitalization of $1.83 billion, a PE ratio of 18.12, a PEG ratio of 1.33 and a beta of 0.89. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.08. The firm’s fifty day simple moving average is $94.33 and its 200 day simple moving average is $101.53.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The firm had revenue of $363.50 million during the quarter, compared to analyst estimates of $366.41 million. During the same quarter in the previous year, the business earned $1.42 EPS. The business’s revenue was up 7.7% on a year-over-year basis. On average, sell-side analysts anticipate that Addus HomeCare Corporation will post 6.24 EPS for the current year.
Insider Activity at Addus HomeCare
In other news, insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider directly owned 44,371 shares in the company, valued at approximately $4,160,668.67. The trade was a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 966 shares of company stock valued at $90,168 in the last 90 days. Insiders own 4.10% of the company’s stock.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
